Transplant Diagnostics Market in terms of revenue was estimated to be worth $4.4 billion in 2022 and is poised to reach $6.8 billion by 2028, growing at a CAGR of 7.4% from 2022 to 2028 according to a new report by MarketsandMarkets™. Organ transplants have gradually improved over the past 20 years and typically produce excellent results in children and young adults. However, the proportion of elderly transplant patients with comorbidities is increasing, posing a greater challenge. When compared to dialysis, renal transplants increase patient survival, and patients with liver, heart, or lung diseases that are incurable must receive life-saving transplants. The activity of solid organ transplant programmes has been steadily increasing, but it still falls short of global needs and varies greatly between nations. Transplanting solid organs is crucial for advanced and established medical systems.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061

Browse in-depth TOC on "Transplant Diagnostics Market" 
168 - Tables 
44 - Figures 
260 - Pages

Transplant Diagnostics Market Scope:

Report Coverage

Details

Market Revenue in 2022

$4.4 billion

Estimated Value by 2028

$6.8 billion

Growth Rate

Poised to grow at a CAGR of 7.4%

Market Size Available for

2020–2028

Forecast Period

2022–2028

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Technology, Product & Service, Application, Transplant type, End User & Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Growing public awareness about organ donation and transplantation

Key Market Drivers

Increasing number of transplant procedures

Molecular assay technologies segment to register a significant growth rate over the forecast period of 2022-2028

Based on Technology, molecular assay technologies are segmented to witness the highest growth during the forecast period. Molecular assay technologies are segmented into PCR-Based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further segmented into Real-time PCR, Sequence-specific primer, Sequence-specific Oligonucleotide and other PCR-based molecular assays.

Sequence-specific Oligonucleotide is growing at the highest CAGR of 9.5%.

The Reagents & Consumables holds the largest share in the Product and Service segment of the Transplant diagnostic market.

The reagents and consumables is projected to reach USD 5,131.0 million from USD USD 3,265.2 million in 2022 with the CAGR of 7.8%.

Based on End users, the transplant diagnostic market is segmented into Hospitals and Diagnostic centers, Research & Academic Institutes and Independent reference laboratories. The Independent reference laboratories segment accounted for the largest share of the transplant diagnostic market. The growing number of organ transplant procedures and growing number of diagnostic labs across emerging countries are helping the independent diagnostic centers to hold the largest share.

North America to register major growth in the market during the forecast period

North America transplant diagnostic market is anticipated to register the highest growth over the forecast period of 2022 to 2028. North America accounted for the largest share of 45.5% of the transplant diagnostic market in 2022. This market is projected to reach USD 3.1 billion by 2028 from USD 2.0 billion in 2022, at a CAGR of 7.6% during the forecast period. North America holds 45.5% share of the total antimicrobial susceptibility testing market. The large share of North America can be attributed due to the growth in the geriatric population and the increase in infectious diseases., Asia-Pacific is expected to experience significant development.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=2531061

Transplant Diagnostics Market Dynamics:

Drivers:

  1. Increasing number of transplant procedures
  2. Technological advancements in transplant diagnostic procedures
  3. Increasing public-private funding for target research activities
  4. Rising prevalence of infectious diseases

Restraints:

  1. High procedural cost of NGS- and PCR-based diagnostic assays
  2. Limited reimbursement for target procedures

Opportunities:

  1. Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation
  2. Growing public awareness about organ donation and transplantation

Challenges:

  1. Significant gap between number of organ donors and organs required annually
  2. Procedural and technical limitations associated with donor-recipient screening

Key Market Players:

As of 2022, prominent players are Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.F-Hoffman-LA-Roche, and Thermo fisher Scientific.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=2531061